| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f16ba7a7f7470c775e84b532d201888
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1375d72bbd9d1c5ba0bc38306319e3b2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 |
| filingDate |
2001-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b348f499f546bda2cb8f9737cf4f7e9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67d2d8ee49018f5c7f7efc715f1edc8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39069ab34efa0d170d4ba4953e85c4af |
| publicationDate |
2003-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0222852-A3 |
| titleOfInvention |
Method for measuring antithrombin activity |
| abstract |
The invention provides a one-stage method of measuring antithrombin (AT) activity in a sample. In the method, a diluted sample is mixed with AT-deficient plasma containing intrinsic coagulation enzymes, an AT augmenting compound such as heparin, a phospholipid and an activator of the contact phase of the intrinsic coagulation pathway. Following addition of calcium ions, coagulation time is measured and compared to a reference standard to determine the level of AT activity in the sample. |
| priorityDate |
2000-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |